United States · FDA National Drug Code directory
Ibrance
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-0189_7dcc9b87-0aa4-4a00-aced-96be3553e8ac
- Product NDC
- 0069-0189
- Form
- CAPSULE
- Composition / generic term
- palbociclib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20150203
- Source listing expiry
- 20271231
Source-listed ingredients
- PALBOCICLIB — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 21 CAPSULE in 1 BOTTLE (0069-0189-21) · 0069-0189-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →